Controlled Clinical Trials as Topic
"Controlled Clinical Trials as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Works about clinical trials involving one or more test treatments, at least one control treatment, specified outcome measures for evaluating the studied intervention, and a bias-free method for assigning patients to the test treatment. The treatment may be drugs, devices, or procedures studied for diagnostic, therapeutic, or prophylactic effectiveness. Control measures include placebos, active medicines, no-treatment, dosage forms and regimens, historical comparisons, etc. When randomization using mathematical techniques, such as the use of a random numbers table, is employed to assign patients to test or control treatments, the trials are characterized as RANDOMIZED CONTROLLED TRIALS AS TOPIC.
| Descriptor ID |
D018849
|
| MeSH Number(s) |
E05.318.760.250.500.365 N05.715.360.775.088.500.387 N06.850.520.450.250.250.365
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Controlled Clinical Trials as Topic".
Below are MeSH descriptors whose meaning is more specific than "Controlled Clinical Trials as Topic".
This graph shows the total number of publications written about "Controlled Clinical Trials as Topic" by people in this website by year, and whether "Controlled Clinical Trials as Topic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 2 | 2 |
| 2001 | 2 | 1 | 3 |
| 2002 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2009 | 1 | 3 | 4 |
| 2010 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2014 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Controlled Clinical Trials as Topic" by people in Profiles.
-
Anton RF. Commentary on: ethyl glucuronide and ethyl sulfate assays in clinical trials, interpretation, and limitations: results of a dose ranging alcohol challenge study and 2 clinical trials. Alcohol Clin Exp Res. 2014 Jul; 38(7):1826-8.
-
Jatlow PI, Agro A, Wu R, Nadim H, Toll BA, Ralevski E, Nogueira C, Shi J, Dziura JD, Petrakis IL, O'Malley SS. Ethyl glucuronide and ethyl sulfate assays in clinical trials, interpretation, and limitations: results of a dose ranging alcohol challenge study and 2 clinical trials. Alcohol Clin Exp Res. 2014 Jul; 38(7):2056-65.
-
Jia Z, Lilly MB, Koziol JA, Chen X, Xia XQ, Wang Y, Skarecky D, Sutton M, Sawyers A, Ruckle H, Carpenter PM, Wang-Rodriguez J, Jiang J, Deng M, Pan C, Zhu JG, McLaren CE, Gurley MJ, Lee C, McClelland M, Ahlering T, Kattan MW, Mercola D. Generation of "virtual" control groups for single arm prostate cancer adjuvant trials. PLoS One. 2014; 9(1):e85010.
-
Griffin WC. Commentary on Marczinski and colleagues: mixing an energy drink with an alcoholic beverage increases motivation for more alcohol in college students. Alcohol Clin Exp Res. 2013 Feb; 37(2):188-90.
-
Back SE. Toward an improved model of treating co-occurring PTSD and substance use disorders. Am J Psychiatry. 2010 Jan; 167(1):11-3.
-
Basile J, Toth PP. Angiotensin receptor blockers: role in hypertension management, cardiovascular risk reduction, and nephropathy. South Med J. 2009 Oct; 102(10 Suppl):S1-S12.
-
Yahyavi-Firouz-Abadi N, See RE. Anti-relapse medications: preclinical models for drug addiction treatment. Pharmacol Ther. 2009 Nov; 124(2):235-47.
-
Durkalski VL, Berger VW. Re-formulating non-inferiority trials as superiority trials: The case of binary outcomes. Biom J. 2009 Feb; 51(1):185-92.
-
Jones HE, O'Grady K, Dahne J, Johnson R, Lemoine L, Milio L, Ordean A, Selby P. Management of acute postpartum pain in patients maintained on methadone or buprenorphine during pregnancy. Am J Drug Alcohol Abuse. 2009; 35(3):151-6.
-
Scott RW, Mughelli K, Deas D. An overview of controlled studies of anxiety disorders treatment in children and adolescents. J Natl Med Assoc. 2005 Jan; 97(1):13-24.